ATOMIX
ATOMIX
ATOrvastatin versus bezafibrate in MIXed hyperlipidemia. A trial evaluating the effect of lipid-lowering therapy on serum chitotriosidase levels, and their usefulness in monitoring lipid-lowering treatment in patients with mixed hyperlipidaemia.Conclusion Serum chitotriosidase levels did not correlate with serum lipids (cholesterol, triglycerides).